• Title of article

    Novel inhibitors of bacterial protein synthesis: structure–activity relationships for 1,8-naphthyridine derivatives incorporating position 3 and 4 variants

  • Author/Authors

    Richard F. Clark، نويسنده , , Sanyi Wang، نويسنده , , Zhenkun Ma، نويسنده , , Moshe Weitzberg، نويسنده , , Christopher Motter، نويسنده , , Michael Tufano، نويسنده , , Rolf Wagner، نويسنده , , Yu Gui Gu، نويسنده , , Peter J. Dandliker، نويسنده , , Claude G. Lerner، نويسنده , , Linda E. Chovan، نويسنده , , Yingna Cai، نويسنده , , Candace L. Black-Schaefer، نويسنده , , Linda Lynch، نويسنده , , Douglas Kalvin، نويسنده , , Angela M. Nilius، نويسنده , , Steve D. Pratt، نويسنده , , Niru Soni، نويسنده , , Tianyuan Zhang، نويسنده , , Xiaolin Zhang، نويسنده , , et al.، نويسنده ,

  • Issue Information
    روزنامه با شماره پیاپی سال 2004
  • Pages
    4
  • From page
    3299
  • To page
    3302
  • Abstract
    Structure–activity relationships for a recently discovered novel ribosome inhibitor (NRI) class of antibacterials were investigated. Preliminary efforts to optimize protein synthesis inhibitory activity of the series through modification of positions 3 and 4 of the naphthyridone lead template resulted in the identification of several biochemically potent analogues. A lack of corresponding whole cell antibacterial activity is thought to be a consequence of poor cellular penetration as evidenced by the enhancement of activity observed for a lead analogue tested in the presence of a cell permeabilizing agent.
  • Journal title
    Bioorganic & Medicinal Chemistry Letters
  • Serial Year
    2004
  • Journal title
    Bioorganic & Medicinal Chemistry Letters
  • Record number

    794584